News | Artificial Intelligence | February 13, 2024

The acquisition further strengthens deepc’s leading-edge solution for radiology 

The acquisition further strengthens deepc’s leading-edge solution for radiology

Photo courtesy of ©deepc


February 13, 2024 —  deepc GmbH, a leading AI operating system for radiologists and enterprise clinical organizations, is pleased to announce the acquisition of the Osimis Platform, a leading medical imaging software solution. This strategic acquisition is a significant milestone in deepc's growth and reflects its commitment to innovation and excellence in the field of radiology. The acquisition gives deepc an enhanced product offering, unmatched technological capabilities, and expanded support and services. 

deepc's market-leading platform solution ‘deepcOS’ provides clinicians with access to a wide variety of Radiology AI solutions, empowering them to make more accurate diagnoses and treatment decisions. With the acquisition of the Osimis Platform, deepc gains not only cutting-edge technology but also invaluable expertise in medical imaging software development. Furthermore, the acquisition consolidates deepc's presence in Europe, strengthening its foothold in key markets and enabling the company to better serve customers across the region.

"At deepc, we are dedicated to supporting clinicians and their institutions with a unified, scalable platform that delivers value and efficiency across the radiology workflow. Our acquisition of the Osimis Platform underscores our commitment to delivering cutting-edge solutions and unparalleled service to our customers," said Dr. Franz Pfister, CEO of deepc GmbH. "We are excited to add Osimis’ industry-leading talent and innovative technology to deepc as we continue to push the boundaries of what's possible in radiology AI."

With this acquisition, customers of both companies can expect an enhanced level of platform functionalities and customer service, marked by quality, reliability, and data safety. For existing customers of Osimis, the acquisition brings access to an expanded range of features and capabilities, backed by deepc's expertise in state-of-the-art AI and deployment of clinical workflow solutions worldwide. The integration of Osimis' technology into deepc's platform will further enhance clinical efficiency and diagnostic accuracy while maintaining the highest standards of data privacy and security under deepc's comprehensive privacy and security framework.

In addition to benefiting customers, this acquisition also signals deepc's strategic growth and consolidation in the radiology AI market. By combining the extensive portfolio of AI solutions, technological expertise, and knowledge of medical imaging, deepc aims to solidify its position as a key player in the industry, driving innovation and setting new standards for excellence.

"We see tremendous potential in joining forces with deepc," said Peter Morel, CEO at Osimis. "Together, we will be able to accelerate innovation, expand our reach, and deliver even greater value to all of our deepc and Osimis customers. We are excited about the opportunities that lie ahead."

 For investors, this acquisition represents a strategic move to consolidate market share and capitalize on the growing demand for AI-driven solutions in radiology. deepc's continued expansion and investment in cutting-edge technologies position the company for sustained growth and success in the years to come.

For more information: www.deepc.ai


Related Content

News | PACS

Aug. 12, 2025 — Rhapsody has announced the general availability of Rhapsody Image Director, an advanced image ...

Time August 12, 2025
arrow
News | X-Ray

Aug. 7, 2025 — Carebot, a technology company specializing in the development of artificial intelligence for X-ray image ...

Time August 07, 2025
arrow
News | Radiology Imaging

July 15, 2025 — Radiology Partners (RP), a provider of technology-enabled radiology services, has announced the launch ...

Time July 15, 2025
arrow
News | Prostate Cancer

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time July 09, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise1 MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

July 1, 2025 — UPDATE: The final paper is now available at: JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics ...

Time July 01, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
Subscribe Now